User menu

Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project.

Bibliographic reference deWitte, TM ; Ferrant, Augustin ; Suciu, Stefan ; Anak, O ; Hagemeijer, Anne ; et. al. Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project..In: Blood, Vol. 94, no. 10, p. 382B-382B (1999)
Permanent URL http://hdl.handle.net/2078.1/62192